STERIS plc (STE) Form 8-K — Nov 4, 2026
$STEForm 8-KItems 1.01, 1.02, 2.03, 9.01Filed Nov 4, 2026, 5:13 PM ET0001193125-26-447617Original filing
STERIS plc entered a new $1,600 million revolving credit agreement on November 4, 2026, replacing its existing revolver, with maturity on November 4, 2031 and pricing tied to STERIS's debt ratings. No borrowings were drawn to replace the prior facility. The company also secured a $500 million delayed draw term loan that can only be used if its acquisition of Xodus Medical, Inc. closes, with commitments terminating if the deal is terminated.
Key figures
- Debt Amount
- 1600000000
- Maturity Date
- 2031-11-04
- Lc commitment
- $150,000,000
- Bridge facility max
- $2,000,000,000
- Delayed draw term loan
- $500 million, contingent on Xodus Medical Acquisition closing
- Applicable margin range
- 0.910%-1.325% (benchmark advances) based on debt rating
- Alternative currency sublimit
- $625 million equivalent
- Incremental revolver capacity
- $800 million
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.